RYCCX
Price
$530.16
Change
+$6.20 (+1.18%)
Updated
Jul 31 closing price
Net Assets
1.59B
RYLDX
Price
$229.37
Change
+$2.30 (+1.01%)
Updated
Jul 31 closing price
Net Assets
43.17M
Interact to see
Advertisement

RYCCX vs RYLDX

RYCCX vs RYLDX Comparison Chart in %
View a ticker or compare two or three
VS
RYCCX vs. RYLDX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYCCX is a StrongBuy and RYLDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYCCX has more cash in the bank: 1.59B vs. RYLDX (43.2M). RYLDX pays higher dividends than RYCCX: RYLDX (0.54) vs RYCCX (0.00). RYCCX was incepted earlier than RYLDX: RYCCX (26 years) vs RYLDX (22 years). RYCCX (2.62) is less costly to investors than RYLDX (1.87). RYLDX is a more actively managed with annual turnover of: 1015.00 vs. RYCCX (383.00). RYCCX (2500) and RYLDX (2500) have matching initial minimum investment requirements. RYLDX annual gain was more profitable for investors over the last year : 33.47 vs. RYCCX (21.42). RYCCX (62.38) and RYLDX (62.04) have equivalent 5 years return.
RYCCXRYLDXRYCCX / RYLDX
Total Expense Ratio2.501.77141%
Annual Report Gross Expense Ratio2.621.87140%
Fund Existence26 years22 years-
Gain YTD17.91015.709114%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.59B43.2M3,683%
Annual Yield % from dividends0.000.54-
Returns for 1 year21.4233.4764%
Returns for 3 years97.3977.12126%
Returns for 5 years62.3862.04101%
Returns for 10 years686.82363.12189%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BAICX10.630.05
+0.49%
BlackRock Multi-Asset Income Investor A
TNBIX21.470.04
+0.20%
1290 SmartBeta Equity I
DRRIX17.740.02
+0.11%
BNY Mellon Global Real Return - I
PARMX40.93-0.04
-0.10%
Parnassus Mid-Cap
LYFCX17.38-0.49
-2.74%
AlphaCentric Life Sciences & Hlthcare C